“Minimally important differences for interpreting the EORTC QLQ-C30 in advanced colorectal cancer patients treated with chemotherapy”

New QLG paper accepted by the journal “Colorectal Disease”:

“Minimally important differences for interpreting the EORTC QLQ-C30 in advanced colorectal cancer patients treated with chemotherapy”

Jammbe Z Musoro  Samantha C Sodergren  Corneel Coens  Alessia Pochesci  Mitsumi Terada  Madeleine T King  Mirjam AG Sprangers  Mogens Groenvold  Kim Cocks  Galina Velikova  Hans‐Henning Flechtner  Andrew Bottomley on behalf of the EORTC Quality of Life, Gastro‐intestinal Groups

This paper presents MIDs to aid the interpretation of EORTC QLQ-C30 change scores in patients with advanced colorectal cancer, treated with chemotherapy. This work is part of the EORTC MID project that aims to gather empirical evidence on patterns of MID estimates across EORTC QLQ-C30 scales and disease sites. Our findings support evidence that scale specific MIDs should be selected with caution.

 

Back to news list